1. Marcos Garcia-Ojeda Marcos Garcia-Ojeda United States says:

    I'm very confused by this paper and the linked citation.  The link citation titled "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion" has nothing to do with T cells.  In this study the authors use a human kidney cell line, 293T, to study if they can inhibit cell fusion mediated by the SARS-CoV2 spike protein using a novel inhibitor EK1C4.  So either the author linked the wrong paper to her publication or she misunderstood the paper cited.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.